A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Clinical trial NCT01910402 · COMPLETED
Trial details
- NCT number
- NCT01910402
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-22
- Primary completion
- 2015-09-22
- Enrollment
- 499
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.